Masthead-Image-Right-min

UnitedHealth Group's Turmoil: The Impact on Labs and Pathology Groups

Rising costs, regulatory scrutiny, and shifting payer dynamics could reshape lab and pathology practice operations and reimbursements.

Continue Reading...

Healthcare's New Law: Preparing for the “One Big Beautiful Bill” Act

The new law brings transformative changes to Medicare, Medicaid, and patient cost-sharing, requiring providers to strategically adapt revenue cycle operations.

Continue Reading...

What's Next for LDTs? A Look Beyond the Ruling

Get the key takeaways from our expert-led webinar on the LDT final rule ruling—and why labs must stay vigilant as the story unfolds.

Continue Reading...

The Road Ahead: 7 RCM Trends to Watch in 2025

Discover the top trends in healthcare revenue cycle management for 2025, including AI, RPA, data analytics, blockchain, and patient engagement strategies.

Continue Reading...

The Potential Impact of the Election on FDA's LDT Final Rule

The election results raise many questions about potential changes to FDA’s enforcement priorities.

Continue Reading...